Portage Biotech Inc.

NASDAQ: PRTG · Real-Time Price · USD
8.55
-0.25 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
8.57
0.23%
After-hours: Aug 15, 2025, 07:52 PM EDT

Portage Biotech Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
36K 51K 54K 41K 27K 12K 1K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-36K -51K -54K -41K -27K -12K -1K -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-11.71M -16.04M -18.2M -19.03M -19.76M -17.48M -16.57M -17M -16.41M -16.08M -15.59M -20.52M -17.22M -15.06M -12.44M -4.54M -4.75M -5.15M
Interest Income
204K 233K 268K 310K 285K 276K 217K 115K 65K 21K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-76.81M -81.52M -85.93M -170.42M -126.85M -124.42M -122.52M -17.16M -15.95M -15.69M -14.82M -20.97M -18.3M -17.6M -14.96M -4.48M -4.79M -3.8M
Net Income
-67.28M -71.08M -75.34M -144.9M -113.01M -108.8M -104.61M -17.48M -13.51M -15.53M -16.87M -21.05M -18.72M -18.2M -15.83M -5.64M -5.77M -4.59M
Selling & General & Admin
5.02M 5.83M 5.67M 6.16M 7.13M 7.52M 8.36M 9.05M 9.07M 8.98M 8.82M 10.07M 8.28M 6.65M 5.13M 65K -96K -49K
Research & Development
6.7M 10.21M 12.53M 12.87M 12.64M 9.96M 8.21M 7.94M 7.33M 7.1M 6.77M 10.52M 9.01M 8.47M 7.38M 4.62M 5M 5.35M
Other Expenses
n/a 15K 26K 26K 27K 12K 1K 1K n/a n/a n/a -65K -65K -65K -65K -150K -150K -150K
Operating Expenses
11.71M 16.06M 18.23M 19.05M 19.79M 17.5M 16.58M 17M 16.41M 16.08M 15.59M 20.52M 17.22M 15.06M 12.44M 4.54M 4.75M 5.15M
Interest Expense
16K 26K 26K 19K 10K 9K 9K 10K 11K 9K 43K 47K 49K 89K 177K 314K 512K 573K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
11.74M 16.08M 18.25M 19.07M 19.79M 17.5M 16.58M 17M 16.41M 16.08M 15.59M 20.52M 17.22M 15.06M 12.44M 4.54M 4.75M 5.15M
Income Tax Expense
-9.49M -10.4M -10.55M -25.5M -13.8M -15.45M -17.86M 1.91M -171K 1.88M 4.35M 1.83M 1.65M 2.85M 2.93M 2.8M 2.87M 2.17M
Shares Outstanding (Basic)
1.08M 1.05M 19.78M 20.9M 17.8M 17.7M 17.61M 17.04M 15.2M 13.35M 13.06M 13.34M 13.33M 12.21M 12.03M 12.03M 11.69M 11.1M
Shares Outstanding (Diluted)
1.08M 1.05M 19.78M 20.9M 17.8M 17.7M 17.61M 17.04M 16.74M 13.35M 13.06M 13.34M 13.33M 12.21M 12.03M 12.03M 11.69M 11.1M
EPS (Basic)
-5.98 -5.01 -3.76 -7.86 -6.42 -6.19 -5.99 -1.19 -1.01 -1.17 -1.29 -1.69 -1.53 -1.52 -1.33 -0.49 -0.51 -2.62
EPS (Diluted)
-5.98 -5.01 -3.76 -7.86 -6.42 -6.19 -5.99 -1.19 -1.01 -1.17 -1.29 -1.69 -1.53 -1.52 -1.33 -0.49 -0.51 -0.42
EBITDA
-78.04M -82.45M -84.6M -169.12M -125.17M -122.79M -121.88M -17.72M -17.05M -16.8M -15.98M -26.37M -23.13M -22.34M -19.61M -4.05M -3.9M -2.9M
EBIT
-78.09M -82.42M -84.58M -169.09M -125.51M -123.19M -122.3M -16.88M -15.82M -15.56M -14.71M -19.98M -17.3M -16.57M -14.27M -6.04M -6.15M -5.1M
Depreciation & Amortization
43K 51K 54K -7.7M -7.71M -4.08M -7.85M -1.23M 2.94M 2.62M 9.98M 7.51M 4.21M 2.05M n/a 2.02M 2.23M 2.63M